Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer
- 1 February 1998
- Vol. 51 (2) , 327-332
- https://doi.org/10.1016/s0090-4295(97)00498-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancerInternational Journal of Cancer, 1996
- Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cellsJournal of Bone and Mineral Research, 1996
- Immunohistochemical Localization of Vascular Endothelial Growth Factor in Esophageal Cancer.The Kurume Medical Journal, 1996
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Tumour necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinomaEuropean Journal Of Cancer, 1994
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994
- Vasculotropin/Vascular Endothelial Growth Factor Induces Differentiation in Cultured OsteoblastsBiochemical and Biophysical Research Communications, 1994
- Vascular endothelial growth factor and its receptorsProgress in Growth Factor Research, 1994
- Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biologyCancer Treatment Reviews, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993